Cyclical Mastalgia (Investigational Adjunct)

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for cyclical mastalgia. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational with case reports only; only chest-wall placement is considered.

What evidence exists?

Tier C (investigational). Only a small case series exists. There are no controlled trials. Cyclical mastalgia is most often related to physiologic premenstrual changes and is managed per ACOG and breast-specialty guidance: reassurance after malignancy exclusion, proper bra support, evening primrose oil (modest evidence), and for severe refractory cases short-course tamoxifen or danazol with substantial side effects. Direct breast leech application carries risk of nipple/areolar discomfort and infection adjacent to ductal structures; only chest-wall placement is considered.

Main risks

• Bleeding from bite sites for 6 to 24 hours after detachment
• Bruising and tenderness over the chest wall for 5 to 10 days
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva
• Substantial bleeding and infection risk if a practitioner inappropriately places a leech on breast tissue or the nipple-areolar complex (this is not appropriate)
• Failure to detect underlying breast pathology if imaging workup is incomplete
• Delay of bra-fit correction, lifestyle modification, and short-course tamoxifen, which are evidence-based
• Worsening of symptoms with no benefit

Who should not consider this

• Patients with suspicion of breast malignancy (BI-RADS 4 or 5)
• Patients with active mastitis or breast abscess
• Pregnant or lactating patients
• Patients with breast implants in place at the proposed site
• Patients with lymphedema after breast surgery
• Anyone offered direct breast or nipple-areolar placement (this is not appropriate)
• Patients on anticoagulants or with severe anemia

What to ask your clinician

• Has breast imaging been performed (clinical breast exam, mammogram, ultrasound) to exclude pathology?
• Have I been properly bra-fitted?
• Have I trialed evening primrose oil, caffeine reduction, and lifestyle modification?
• Has short-course luteal-phase tamoxifen been considered for severe disease?
• Where exactly will the leech be placed — confirm chest-wall skin lateral to breast tissue?
• What is the realistic expected benefit, given evidence is one small case series?

When to seek urgent care

• A new lump or persistent focal area of pain or thickening in the breast
• Skin changes (peau d'orange, dimpling), nipple inversion or discharge
• Spreading redness, warmth, or swelling of the breast (mastitis or inflammatory breast cancer)
• Fever above 38.0 C / 100.4 F or chills
• Bleeding from a bite site lasting more than 24 hours
• Spreading redness, warmth, pus, or red streaks at any bite site